In addition to their hypoglycemic effects, DPP-4 inhibitors have also been shown to exert anti-inflammatory and anti-atherosclerotic effects against cardiovascular diseases [21,22] and an anti-inflammatory effect in experimental models of sepsis [17,23]. Here, DPP4 is linked to cardiovascular disorder.